LOS ANGELES — City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving cures for patients with cancer, diabetes and other chronic, life-threatening diseases. Each spotlight features research-related news, such as recognitions, collaborations and the latest research defining the future of medical treatment.
This roundup highlights diabetes research, the role of obesity in multiple myeloma, results from a clinical trial of a new liquid biopsy for evaluating potential responses to epidermal growth factor receptor (EGFR) inhibitors in metastatic colorectal cancers, the discovery of a biomarker that could predict a patient's response to immune checkpoint inhibitors, a scientific statement from the American Heart Association on addressing cardiovascular toxicity in patients who had pediatric cancers and a study of a new medication that helps stop leukemia cells from decreasing the activity of the immune system.
